Abstract
AbstractBovine respiratory disease (BRD) treatment failure occurs when animals receiving a treatment regimen for BRD fail to directly return to health, resulting in chronic illness and a requirement for repeated treatments, sale for salvage slaughter, euthanasia or death. BRD treatment failure has both direct and indirect impacts. Direct impacts include costs to manage chronically ill animals, including those associated with BRD relapse treatment; reduced returns from animals sent for salvage slaughter, loss of the initial investment to purchase the animal and feed and other accumulated expenses to death, and costs associated with carcass disposal. Indirect impacts include costs of infrastructure requirements, and negative effects on animal welfare and employee morale.
Publisher
Cambridge University Press (CUP)
Subject
Animal Science and Zoology
Reference5 articles.
1. Prudent use guidelines: a review of existing veterinary guidelines
2. An evaluation of the relative efficacy of tulathromycin for the treatment of undifferentiated fever in feedlot calves in Nebraska;Schunicht;Canadian Veterinary Journal,2007
3. Feedlot Pharmaceutical Documentation
4. Comparison of enrofloxacin and ceftiofur sodium for the treatment of relapse of undifferentiated fever/bovine respiratory disease in feedlot cattle;Abutarbush;Canadian Veterinary Journal,2012
5. A retrospective analysis of risk factors associated with bovine respiratory disease treatment failure in feedlot cattle;Avra;Journal of Animal Science,2017
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献